{"id":409434,"date":"2021-01-06T08:08:14","date_gmt":"2021-01-06T13:08:14","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=409434"},"modified":"2021-01-06T08:08:14","modified_gmt":"2021-01-06T13:08:14","slug":"tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/","title":{"rendered":"TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, Jan.  06, 2021  (GLOBE NEWSWIRE) &#8212; TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Virtual BioConnect 2021 Conference, being held January 11-14, 2021.<\/p>\n<p align=\"justify\">The presentation will be available on-demand beginning on Monday, January 11, 2021, in the Investors section on the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rMZZ6urAsDWElVVcm6MOYuzmLqttaEBxMm-6yhgjO3b3bcSdY0417ThCJBFKpr69OUj-FTGuQOupvIfVNRbXDwGdNTz_gpBp_fJqq344A5OGRbGBGmmE3PtCqlSj8mg2q0hEAhtD0pg4Ve11qtsFacIT73zQCZGxtZRM6ldW9Z4f3lRGQOP_RWGwxLzbZc3qPFoOp6AEi-v358vxPsafgF6zoYrOxh-s6pdYU1cuv78dhOKFYXUA_hpmo9VyqPoRpOCAToKw-ahG0i2Qt4mwYw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.traconpharma.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About TRACON<\/strong>\n      <\/p>\n<p align=\"justify\">TRACON develops targeted therapies for cancer utilizing a capital efficient, CRO independent, product development platform. The Company\u2019s clinical-stage pipeline includes: Envafolimab, a subcutaneous PD-L1 single-domain antibody being developed in a registration trial for the treatment of certain sarcomas; TRC253, a small molecule drug candidate for the treatment of prostate cancer; TRC102, a Phase 2 small molecule drug candidate being developed for the treatment of lung cancer and glioblastoma; and TJ004309, a CD73 antibody in Phase 1 development for the treatment of advanced solid tumors. TRACON is actively seeking additional corporate partnerships whereby it leads U.S. regulatory and clinical development and shares in the cost and risk of clinical development and leads U.S. commercialization.\u00a0 In these partnerships TRACON believes it can serve as a solution for companies without clinical and commercial capabilities in the U.S.\u00a0 To learn more about TRACON and its product pipeline, visit TRACON&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rMZZ6urAsDWElVVcm6MOYlkE6zHp2AuOJMXV5X0uLFe7cW5TUxFV_R4leqG62wyEq4XVg7Zj0PWR9jpZXp75v-kH7KimgDibWCls6NaM4lM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.traconpharma.com<\/u><\/a>.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <u>Company Contact<\/u>:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <u>Investor Contact<\/u>:<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Mark Wiggins<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Andrew McDonald<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Chief Business Officer<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">LifeSci Advisors LLC<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">(858) 251-3492<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">646-597-6987<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <a href=\"mailto:mwiggins@traconpharma.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">mwiggins@traconpharma.com<\/a>\n          <\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <a href=\"mailto:Andrew@lifesciadvisors.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Andrew@lifesciadvisors.com<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTEzOSMzOTA2MDgyIzIwMTYxODg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/7c72e8b4-f815-4b32-8665-1eeddf9e703e\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Virtual BioConnect 2021 Conference, being held January 11-14, 2021. The presentation will be available on-demand beginning on Monday, January 11, 2021, in the Investors section on the Company\u2019s website at www.traconpharma.com. About TRACON TRACON develops targeted therapies for cancer utilizing a capital efficient, CRO independent, product development platform. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-409434","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Virtual BioConnect 2021 Conference, being held January 11-14, 2021. The presentation will be available on-demand beginning on Monday, January 11, 2021, in the Investors section on the Company\u2019s website at www.traconpharma.com. About TRACON TRACON develops targeted therapies for cancer utilizing a capital efficient, CRO independent, product development platform. &hellip; Continue reading &quot;TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-06T13:08:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTEzOSMzOTA2MDgyIzIwMTYxODg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference\",\"datePublished\":\"2021-01-06T13:08:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/\"},\"wordCount\":294,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTEzOSMzOTA2MDgyIzIwMTYxODg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/\",\"name\":\"TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTEzOSMzOTA2MDgyIzIwMTYxODg=\",\"datePublished\":\"2021-01-06T13:08:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTEzOSMzOTA2MDgyIzIwMTYxODg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTEzOSMzOTA2MDgyIzIwMTYxODg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/","og_locale":"en_US","og_type":"article","og_title":"TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference - Market Newsdesk","og_description":"SAN DIEGO, Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Virtual BioConnect 2021 Conference, being held January 11-14, 2021. The presentation will be available on-demand beginning on Monday, January 11, 2021, in the Investors section on the Company\u2019s website at www.traconpharma.com. About TRACON TRACON develops targeted therapies for cancer utilizing a capital efficient, CRO independent, product development platform. &hellip; Continue reading \"TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-06T13:08:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTEzOSMzOTA2MDgyIzIwMTYxODg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference","datePublished":"2021-01-06T13:08:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/"},"wordCount":294,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTEzOSMzOTA2MDgyIzIwMTYxODg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/","name":"TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTEzOSMzOTA2MDgyIzIwMTYxODg=","datePublished":"2021-01-06T13:08:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTEzOSMzOTA2MDgyIzIwMTYxODg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTEzOSMzOTA2MDgyIzIwMTYxODg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tracon-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-2021-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=409434"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409434\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=409434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=409434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=409434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}